Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: A multitumour array analysis

British Journal of Cancer

Volumn 109, Issue 7, 2013, Pages 1848-1858

  Reeh, M ^a   Bockhorn, M ^a   Gorgens D ^b   Vieth, M ^b   Hoffmann, T ^a   Simon, R ^a   Izbicki, J R ^a   Sauter, G ^a   Schumacher, U ^a   Anders, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Coxsackievirus and Adenovirus receptor; differential expression; multitumour tissue microarray

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR;

ADENOSQUAMOUS CARCINOMA; ADENOVIRUS; ANUS CANCER; ARTICLE; ASTROCYTOMA; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CARCINOSARCOMA; CHONDROSARCOMA; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; COXSACKIE VIRUS; DERMATOFIBROSARCOMA PROTUBERANS; ENDOMETRIUM CANCER; EPENDYMOMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; GALLBLADDER CARCINOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LEIOMYOMA; LEIOMYOSARCOMA; LIPOSARCOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT MESOTHELIOMA; MALIGNANT NEURILEMOMA; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; MELANOMA; MOUTH CARCINOMA; NEOPLASM; NEUROBLASTOMA; NEUROFIBROMA; NONHODGKIN LYMPHOMA; OLIGODENDROGLIOMA; ONCOCYTOMA; OVARY CANCER; PANCREAS ADENOCARCINOMA; PARAGANGLIOMA; PENIS CARCINOMA; PHEOCHROMOCYTOMA; PILOMATRIXOMA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SEMINOMA; SMALL INTESTINE CARCINOMA; STOMACH CANCER; TESTIS NONSEMINOMA CANCER; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; UTERINE CERVIX CANCER; VAGINA CARCINOMA; VULVA CARCINOMA; WARTHIN TUMOR;

ADENOVIRIDAE INFECTIONS; CELL TRANSFORMATION, NEOPLASTIC; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; COXSACKIEVIRUS INFECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROTEIN ARRAY ANALYSIS;

EID: 84885185475     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.509     Document Type: Article

References (46)

1. Anders M, Christian C, McMahon M, McCormick F, Korn WM (2003a) Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res 63: 2088-2095.
2. Anders M, Hansen R, Ding R-X, Rauen KA, Bissell MJ, Korn WM (2003b) Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci USA 100: 1943-1948.
3. Anders M, Vieth M, Röcken C, Ebert M, Pross M, Gretschel S, Schlag PM, Wiedenmann B, Kemmner W, Höcker M (2009) Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. Br J Cancer 100: 352-359.
4. Arnberg N (2012) Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci 33: 442-448.
5. Auer D, Reimer D, Porto V, Fleischer M, Roessler J, Wiedemair A, Marth C, Müller-Holzner E, Daxenbichler G, Zeimet AG (2009) Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. Breast Cancer Res Treat 116: 103-111.
6. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
7. Brüning A, Runnebaum IB (2003) CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther 10: 198-205.
8. Brüning A, Runnebaum IB (2004) The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res 298: 624-631.
9. Brüning A, Stickeler E, Diederich D, Walz L, Rohleder H, Friese K, Runnebaum IB (2005) Coxsackie and adenovirus receptor promotes adenocarcinoma cell survival and is expressionally activated after transition from preneoplastic precursor lesions to invasive adenocarcinomas. Clin Cancer Res 11: 4316-4320.
10. Buscarini M, Quek ML, Gilliam-Hegarich S, Kasahara N, Bochner B (2007) Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. Urol Int 78: 160-166.
11. Chen Z, Wang Q, Sun J, Gu A, Jin M, Shen Z, Qiu Z, Wang J, Wang X, Zhan Z, Li J-W (2013) Expression of the coxsackie and adenovirus receptor in human lung cancers. Tumour Biol 34: 17-24.
12. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM (2001) The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98: 15191-15196.
13. Dietel M, Häfner N, Jansen L, Dürst M, Runnebaum IB (2011) Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis. J Mol Med 89: 621-630.
14. Giaginis C, Zarros A, Alexandrou P, Klijanienko J, Delladetsima I, Theocharis S (2010) Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions. Apmis 118: 210-221.
15. Giaginis CT, Zarros AC, Papaefthymiou MA, Papadopouli AE, Sfiniadakis IK, Theocharis SE (2008) Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implications. World J Surg Oncol 6: 59.
16. Heideman DA, Snijders PJ, Craanen ME, Bloemena E, Meijer CJ, Meuwissen SG, van Beusechem VW, Pinedo HM, Curiel DT, Haisma HJ, Gerritsen WR (2001) Selective gene delivery toward gastric and oesophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors. Cancer Gene Ther 8: 342-351.
17. Huang K-C, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L, Holland PC, Nalbantoglu J (2005) Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. Int J Cancer 113: 738-745.
18. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96: 25-34.
19. Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, Kanazumi N, Nomoto S, Sugimoto H, Nakao A (2007) Oncolytic virus therapy-foreword. Curr Cancer Drug Targets 7: 123-125.
20. Korn WM, Macal M, Christian C, Lacher MD, McMillan A, Rauen KA, Warren RS, Ferrell L (2006) Expression of the coxsackievirus-and adenovirus receptor in gastrointestinal cancer correlates with tumour differentiation. Cancer Gene Ther 13: 792-797.
21. Küster K, Grötzinger C, Koschel A, Fischer A, Wiedenmann B, Anders M (2010a) Sodium butyrate increases expression of the coxsackie and adenovirus receptor in colon cancer cells. Cancer Invest 28: 268-274.
22. Küster K, Koschel A, Rohwer N, Fischer A, Wiedenmann B, Anders M (2010b) Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1alpha. Cancer Gene Ther 17: 141-146.
23. Lacher MD, Shiina M, Chang P, Keller D, Tiirikainen MI, Korn WM (2011) ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor. Mol Cancer 10: 91.
24. Lacher MD, Tiirikainen MI, Saunier EF, Christian C, Anders M, Oft M, Balmain A, Akhurst RJ, Korn WM (2006) Transforming growth factorbeta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. Cancer Res 66: 1648-1657.
25. Ma J, Zhao J, Lu J, Jiang Y, Yang H, Li P, Zhao M, Liu K, Dong Z (2012) Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in oesophageal cancer. Int J Mol Med 30: 1403-1409.
26. Marsee DK, Vadysirisack DD, Morrison CD, Prasad ML, Eng C, Duh Q-Y, Rauen KA, Kloos RT, Jhiang SM (2005) Variable expression of coxsackieadenovirus receptor in thyroid tumors: implications for adenoviral gene therapy. Thyroid 15: 977-987.
27. Martin TA, Watkins G, Jiang WG (2005) The Coxsackie-adenovirus receptor has elevated expression in human breast cancer. Clin Exp Med 5: 122-128.
28. Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP (2000) The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271: 99-108.
29. Matsumoto K, Shariat SF, Ayala GE, Rauen KA, Lerner SP (2005) Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66: 441-446.
30. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT (2000) The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 60: 5031-5036.
31. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT (2001) The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 61: 6592-6600.
32. Pazirandeh A, Sultana T, Mirza M, Rozell B, Hultenby K, Wallis K, Vennström B, Davis B, Arner A, Heuchel R, Löhr M, Philipson L, Sollerbrant K (2011) Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene. PLoS One 6: e20203.
33. Persson A, Fan X, Widegren B, Englund E (2006) Cell type-and regiondependent coxsackie adenovirus receptor expression in the central nervous system. J Neurooncol 78: 1-6.
34. Pong R-C, Lai Y-J, Chen H, Okegawa T, Frenkel E, Sagalowsky A, Hsieh J-T (2003) Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 63: 8680-8686.
35. Raschperger E, Thyberg J, Pettersson S, Philipson L, Fuxe J, Pettersson RF (2006) The coxsackie-and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 312: 1566-1580.
36. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F (2002) Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 62: 3812-3818.
37. Reimer D, Steppan I, Wiedemair A, Concin N, Hofstetter G, Marth C, Müller-Holzner E, Zeimet AG (2007) Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer. Int J Cancer 120: 2568-2575.
38. Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP, Rodriguez R (2002) Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology 60: 531-536.
39. Simon R, Sauter G (2002) Tissue microarrays for miniaturized highthroughput molecular profiling of tumors. Exp Hematol 30: 1365-1372.
40. Stecker K, Vieth M, Koschel A, Wiedenmann B, Röcken C, Anders M (2011) Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. Br J Cancer 104: 1426-1433.
41. Wang B, Chen G, Li F, Zhou J, Lu Y, Ma D (2005) Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3. J Huazhong Univ Sci Technol Med Sci 25: 85-8793.
42. Wang Y, Wang S, Bao Y, Ni C, Guan N, Zhao J, Salford LG, Widegren B, Fan X (2006) Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers. J Mol Histol 37: 153-160.
43. Wunder T, Schmid K, Wicklein D, Groitl P, Dobner T, Lange T, Anders M, Schumacher U (2012a) Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Ther 20(1): 25-32.
44. Wunder T, Schumacher U, Friedrich RE (2012b) Coxsackie adenovirus receptor expression in carcinomas of the head and neck. Anticancer Res 32: 1057-1062.
45. You Z, Fischer DC, Tong X, Hasenburg A, Aguilar-Cordova E, Kieback DG (2001) Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression. Cancer Gene Ther 8: 168-175.
46. Zhang N-H, Song L-B, Wu X-J, Li R-P, Zeng M-S, Zhu X-F, Wan D-S, Liu Q, Zeng Y-X, Zhang X-S (2008) Proteasome inhibitor MG-132 modifies coxsackie and adenovirus receptor expression in colon cancer cell line lovo. Cell Cycle 7: 925-933.